A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Overview of attention for article published in Journal of Hepatology, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 10 news outlets
twitter: 25 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 30 X posts from 25 X users, with an upper bound of 104,261 followers.

RT @AEEHLiver: 📖A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encepha…

📖A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy 💊Golexanolone vs placebo 👍Buen perfil seguridad 👉Tendencia a mejoría en los test de EH #livertwitter #openaccess htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.